Which surgery is safer for a dangerous placenta condition?

NCT ID NCT06861972

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial compares two surgical strategies for managing placenta accreta, a condition where the placenta grows too deeply into the uterine wall and can cause severe bleeding during delivery. One approach is a caesarean hysterectomy, which removes the uterus after the baby is born. The other is conservative surgery that removes only the affected area of the uterine muscle. The study will look at blood loss, need for transfusions, injuries to nearby organs, and recovery time to see which method may be safer for women with this high-risk pregnancy complication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Caesarean hysterectomy (removal of the uterus after caesarean delivery) compared with conservative management (removing only the affected part of the uterine muscle).
What this could lead to
If one approach proves safer, it could guide doctors in choosing the best surgical option for women with placenta accreta, potentially reducing severe bleeding and complications.
What could go wrong
This is a small study, and results may not apply to all cases. Both procedures carry risks like heavy bleeding, injury to nearby organs, and the need for blood transfusions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSTETRIC COMPLICATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cairo University Hospitals

    Cairo, 11261, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.